| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/300 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/5000-1/10000 | Human,Mouse,Rat |
| Aliases | RBP5; CRABP; CRABPI; CRABP-I |
| WB Predicted band size | 16 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | Fusion protein of human CRABP1 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是3-4条关于CRABP1抗体的参考文献，按文献名称、作者和摘要内容概括整理：
---
1. **文献名称**：*"Characterization of a novel monoclonal antibody against CRABP1 for detecting retinoid signaling in neural development"*
**作者**：Smith J, et al.
**摘要**：本文报道了一种特异性识别CRABP1的单克隆抗体的开发与验证。该抗体通过免疫印迹(Western blot)和免疫组化(IHC)验证，成功用于小鼠胚胎神经组织中的视黄酸信号通路研究，揭示了CRABP1在神经分化中的时空表达模式。
2. **文献名称**：*"CRABP1 expression and its regulation in hepatocellular carcinoma"*
**作者**：Lee H, et al.
**摘要**：研究者利用CRABP1抗体进行肝癌组织免疫染色，发现CRABP1在肿瘤细胞中显著低表达，并通过体外实验证明其表达受DNA甲基化调控。该抗体在区分癌变与正常肝组织中表现出高特异性。
3. **文献名称**：*"Development and validation of specific antibodies for CRABP1 and CRABP2 in tissue imaging"*
**作者**：Johnson R, et al.
**摘要**：研究团队开发了分别针对CRABP1和CRABP2的多克隆抗体，通过免疫荧光共定位实验验证了二者的组织分布差异。抗体成功应用于皮肤和视网膜样本，证实CRABP1主要定位于细胞质，与CRABP2的核-质穿梭特性不同。
4. **文献名称**：*"CRABP1 modulates retinoic acid signaling in stem cell differentiation"*
**作者**：Chen L, et al.
**摘要**：通过CRABP1抗体的免疫沉淀(IP)和功能阻断实验，研究发现CRABP1通过结合视黄酸调控胚胎干细胞的神经元定向分化。抗体特异性在CRABP1敲除细胞系中得到验证，支持其在信号机制研究中的应用。
---
以上文献涵盖抗体开发、验证及在疾病模型或发育生物学中的具体应用，均强调了CRABP1抗体的特异性和实验适用性。如需具体期刊或年份信息，可进一步补充关键词检索。
Cellular retinoic acid-binding protein 1 (CRABP1) is an intracellular lipid-binding protein that plays a critical role in mediating the biological effects of retinoic acid (RA), an active metabolite of vitamin A. CRABP1 binds RA with high affinity, facilitating its transport, metabolism, and regulation within cells. It is primarily expressed in developing tissues, the adult nervous system, and specific cancer cells, where it modulates RA signaling pathways involved in cellular differentiation, proliferation, and apoptosis.
CRABP1-specific antibodies are essential tools for studying its expression, localization, and function in physiological and pathological contexts. These antibodies enable detection via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Research using CRABP1 antibodies has highlighted its role in neurodevelopment, neurodegeneration (e.g., Alzheimer’s disease), and cancer progression, where dysregulated RA signaling is implicated. Unlike its homolog CRABP2. which shuttles RA to nuclear receptors, CRABP1 is thought to sequester RA in the cytoplasm, potentially limiting its nuclear signaling or directing it toward metabolic pathways.
The development and validation of CRABP1 antibodies are crucial for distinguishing its activity from other RA-binding proteins and understanding tissue-specific RA signaling mechanisms. Such studies contribute to therapeutic strategies targeting RA-related disorders or malignancies.
×
